Development of a structured clinical pharmacology review for specialist support for management of complex polypharmacy in primary care
- 14 February 2020
- journal article
- review article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 86 (7) , 1326-1335
Abstract
Aims: Polypharmacy is widespread and associated with medication‐related harms, including adverse drug reactions, medication errors and poor treatment adherence. General practitioners and pharmacists cite limited time and training to perform effective medication reviews for patients with complex polypharmacy, yet no specialist referral mechanism exists. To develop a structured framework for specialist review of primary care patients with complex polypharmacy.Methods: We developed the clinical pharmacology structured review (CPSR) and stopping by indication tool (SBIT). We tested these in an age‐sex stratified sample of 100 people with polypharmacy aged 65–84 years from the Clinical Practice Research Datalink, an anonymised primary care database. Simulated medication reviews based on electronic records using the CPSR and SBIT were performed. We recommended medication changes or review to optimise treatment benefits, reduce risk of harm or reduce treatment burden.Results: Recommendations were made for all patients, for almost half (4.8 ± 2.4) of existing medicines (9.8 ± 3.1), most commonly stopping a drug (1.7 ± 1.3/patient) or reviewing with the patient (1.4 ± 1.2/patient). At least 1 new medicine (0.7 ± 0.9) was recommended for 51% patients. Recommendations predominantly aimed to reduce harm (44%). There was no relationship between number of recommendations made and time since last primary care medication review. We identified a core set of clinical information and investigations (polypharmacy workup) that could inform a standard screen prior to specialist review.Conclusion: The CPSR, SBIT and polypharmacy workup could form the basis of a specialist review for patients with complex polypharmacy. Further research is needed to test this approach in patients in general practice.Keywords
This publication has 33 references indexed in Scilit:
- Multimorbidity in bipolar disorder and undertreatment of cardiovascular disease: a cross sectional studyBMC Medicine, 2013
- Completeness and usability of ethnicity data in UK-based primary care and hospital databasesJournal of Public Health, 2013
- Quality of prescribing in care homes and the community in England and WalesBritish Journal of General Practice, 2012
- Adverse cardiovascular outcomes associated with concurrent use of clopidogrel or ticlopidine and proton-pump inhibitors in patients undergoing percutaneous coronary interventionHeart and Vessels, 2012
- Medication Adherence Among Geriatric Outpatients Prescribed Multiple MedicationsThe American Journal of Geriatric Pharmacotherapy, 2012
- Preventable and Non-Preventable Adverse Drug Events in Hospitalized PatientsDrug Safety, 2011
- Current Guidelines Have Limited Applicability to Patients with Comorbid Conditions: A Systematic Analysis of Evidence-Based GuidelinesPLOS ONE, 2011
- Disparate Inclusion of Older Adults in Clinical Trials: Priorities and Opportunities for Policy and Practice ChangeAmerican Journal of Public Health, 2010
- Potential Pitfalls of Disease-Specific Guidelines for Patients with Multiple ConditionsNew England Journal of Medicine, 2004
- A method for assessing drug therapy appropriateness☆Journal of Clinical Epidemiology, 1992